EP0245480A1 - Application transdermique de nicotine - Google Patents
Application transdermique de nicotineInfo
- Publication number
- EP0245480A1 EP0245480A1 EP86907172A EP86907172A EP0245480A1 EP 0245480 A1 EP0245480 A1 EP 0245480A1 EP 86907172 A EP86907172 A EP 86907172A EP 86907172 A EP86907172 A EP 86907172A EP 0245480 A1 EP0245480 A1 EP 0245480A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- tobacco
- patch
- nicotine
- skin
- nicotine patch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 title claims abstract description 33
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 title claims abstract description 32
- 229960002715 nicotine Drugs 0.000 title claims abstract description 32
- 241000208125 Nicotiana Species 0.000 claims abstract description 88
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims abstract description 88
- 230000000391 smoking effect Effects 0.000 claims description 19
- 235000019504 cigarettes Nutrition 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 235000019506 cigar Nutrition 0.000 claims description 6
- 235000011187 glycerol Nutrition 0.000 claims description 5
- 239000002985 plastic film Substances 0.000 claims description 4
- 229920006255 plastic film Polymers 0.000 claims description 4
- 108010010803 Gelatin Proteins 0.000 claims description 3
- 239000000470 constituent Substances 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 2
- 239000002002 slurry Substances 0.000 claims description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 2
- 230000002378 acidificating effect Effects 0.000 claims 2
- 230000037213 diet Effects 0.000 claims 1
- 235000005911 diet Nutrition 0.000 claims 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 claims 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 claims 1
- 239000000779 smoke Substances 0.000 abstract description 7
- 239000000047 product Substances 0.000 description 7
- 239000006227 byproduct Substances 0.000 description 5
- 238000002485 combustion reaction Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000003570 air Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000002411 adverse Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 235000002918 Fraxinus excelsior Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000012080 ambient air Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000002956 ash Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 239000007933 dermal patch Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000008376 long-term health Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- MILWSGRFEGYSGM-UHFFFAOYSA-N propane-1,2-diol;propane-1,2,3-triol Chemical compound CC(O)CO.OCC(O)CO MILWSGRFEGYSGM-UHFFFAOYSA-N 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F47/00—Smokers' requisites not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
Definitions
- This invention relates to tobacco skin patches designed to reduce or eliminate the disadvantages associated with conventional smoking habits using combustible tobacco.
- the field is patches used in the absorbtion of tobacco nicotine through the skin.
- the amount of nicotine absorbed into the body generally does not build up to a harmful dose, but produces certain pleasurable effects, frequently leading to habitual use.
- the relative mildness of a tobacco cigarette as compared to a pipe or cigar permits a user to draw the smoke from the burning cigarette directly into the lungs.
- the nicotine vapors in the tobacco smoke are rapidly assim ⁇ ilated into the bloodstream of the user from the lungs, so that tobacco smoking provides a method by which a user may very quickly feel the effects of the nicotine.
- Tobacco concentrates for example, have been processed into a tablet form which may be sucked or chewed in the mouth of the user, the nicotine being absorbed into the user's body through the lining of the mouth.
- the tobacco in this method may be heated by various pyrophorous materials, which are mixed together with the tobacco. Such materials react with oxygen, alcohol, water, etc. and thereby produce sufficient heat to cause the tobacco to release vapors.
- any by-products of the com ⁇ bustion reaction which occurs within the tobacco mix, will also tend to be inhaled through the device by the user.
- the structure of such devices tend to be unduly complex, resulting in a relatively high manufacturing cost.
- Various other smoking substitutes have been developed which include cigarette simulating devices containing various materials which approximate the taste and aroma of tobacco or release various other additional aromatic vapors which are intended to have a satisfying effect on the user when those vapors are inhaled.
- synthetic materials simulating the taste and aroma of tobacco are micro-encapsulated within a cigarette device. The desired vapors are released by squeezing or crushing the device.
- a tobacco nicotine product containing one or all sufficient quantity of finely powdered cigar, cigarette, chew snuff and leaf tobacco which can be mixed into a slurry and made into reconstituted tobacco sheet or made as a reconstituted tobacco sheet on a standard paper making machine (fortenier). Cut into size of any reasonable dimension.
- Glycerin, alcohol or water separately or mixed are applied to skin and/or product then the patch of tobacco is placed on same area of skin.
- Cover patch of tobacco with any plastic film or any product that holds in body heat. When body heat builds under plastic film, nicotine vapors are absorbed into the user's body, which give them the stimulation of tobacco without lighting up.
- This invention can also be applied with fine ground tobaccos being added to creams, oil, alcohol, propylene glycol-glycerin, water, gelatin, gura gum, or a solid piece and applied to the skin wrapped or not wrapped or covered by any material; in any form or solid.
- Any type of tobacco, cigar, cigarette, chew, leaf, and snuff can be added to product from 1% tobacco to 100% tobacco, in any form including leaf.
- This Invention is used so a person wanting to stop smoking combustible tobacco can place a patch of uncombustible tobacco on the skin to get the sensation of nicotine from smoking without lighting up.
- the tobacco patch is a simple method for nicotine replacement. It is medically acknowledged that the tar and gases such as carbon monoxide, oxides of nitrogen, and many other toxic com ⁇ bustion products are the principal culprits that cause s oking-related cancer, bronchitis and possibly heart disease. Simple nicotine replacement by other means would seem a logical and straightforward method to "kick the habit.” DESCRIPTION OF DRAWING:
- Figure 1 shows my tobacco patch invention having a tobacco sheet patch (1), film (2) and glycerin, alcohol or water separately or mixed (3).
- This invention is a patch having tobacco designed to be wrapped on to the skin and releasing tobacco nicotine through skin temperature.
- the patch of tobacco is a sheet made from one or all of finely powdered cigar, cigarette, chew snuff and leaf tobacco.
- a plastic film or any product which holds in body heat covers the tobacco patch when applied to the skin.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Manufacture Of Tobacco Products (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Une application transcutanée de nicotine est effectuée à l'aide d'une compresse munie d'une pellicule (2) contenant du tabac (1) servant de source de micotine. La compresse est conçue pour être appliquée sur la peau. L'application transcutanée de nicotine réduit l'envie de fumer.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US79793885A | 1985-11-14 | 1985-11-14 | |
| US797938 | 1985-11-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP0245480A1 true EP0245480A1 (fr) | 1987-11-19 |
Family
ID=25172154
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP86907172A Pending EP0245480A1 (fr) | 1985-11-14 | 1986-11-13 | Application transdermique de nicotine |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP0245480A1 (fr) |
| AU (1) | AU6630086A (fr) |
| WO (1) | WO1987002870A1 (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4839174A (en) * | 1987-10-05 | 1989-06-13 | Pharmetrix Corporation | Novel transdermal nicotine patch |
| US4781924A (en) | 1987-11-09 | 1988-11-01 | Alza Corporation | Transdermal drug delivery device |
| US5004610A (en) * | 1988-06-14 | 1991-04-02 | Alza Corporation | Subsaturated nicotine transdermal therapeutic system |
| US5077104A (en) * | 1989-12-21 | 1991-12-31 | Alza Corporation | Nicotine packaging materials |
| US5508038A (en) * | 1990-04-16 | 1996-04-16 | Alza Corporation | Polyisobutylene adhesives for transdermal devices |
| DE4416927C1 (de) * | 1994-05-13 | 1995-08-31 | Lohmann Therapie Syst Lts | Vorrichtung zur Abgabe von Wirkstoffen aus Haftschmelzklebern, Verfahren zu ihrer Herstellung und ihre Verwendung |
| DE4433191A1 (de) * | 1994-09-17 | 1996-03-21 | Lohmann Therapie Syst Lts | Selbstklebendes Pflaster zur Abgabe von Wirkstoff an die Umgebung eines Trägers |
| GB2446672A (en) * | 2007-02-14 | 2008-08-20 | Cotrex Llc | Tobacco extraction methods and formulations |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA930668A (en) * | 1969-04-01 | 1973-07-24 | Zaffaroni Alejandro | Bandage for administering drugs |
| GB8301659D0 (en) * | 1983-01-21 | 1983-02-23 | Leo Ab | Smoking substitutes |
-
1986
- 1986-11-13 WO PCT/US1986/002445 patent/WO1987002870A1/fr not_active Ceased
- 1986-11-13 EP EP86907172A patent/EP0245480A1/fr active Pending
- 1986-11-13 AU AU66300/86A patent/AU6630086A/en not_active Abandoned
Non-Patent Citations (1)
| Title |
|---|
| See references of WO8702870A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU6630086A (en) | 1987-06-02 |
| WO1987002870A1 (fr) | 1987-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4813437A (en) | Nicotine dispensing device and method for the manufacture thereof | |
| US4284089A (en) | Simulated smoking device | |
| CA1116969A (fr) | Cigarette non combustible | |
| US5284163A (en) | Means for use as an aid to stop smoking or for use in non-smoking areas | |
| KR100598131B1 (ko) | 밀폐형 흡연장치 | |
| US5293883A (en) | Non-combustible anti-smoking device with nicotine impregnated mouthpiece | |
| EP0749278B1 (fr) | Dispositif d'administration de nicotine par voie orale | |
| RU2183418C2 (ru) | Разновидность сигарет (варианты) | |
| US20050236006A1 (en) | Smoking cessation devices, methods of use and methods of conducting business therewith | |
| EP0202512A2 (fr) | Distributeur de nicotine avec un réservoir de nicotine en polymère | |
| US4807648A (en) | Non-burning tobacco substitute | |
| JPH06114105A (ja) | タバコまたは薬品成分の無煙吸引摂取用具および方法 | |
| US7614402B2 (en) | Simulated cigarette | |
| EP0148749A2 (fr) | Préparation contenant de la nicotine | |
| US4821745A (en) | Apparatus and method for overcoming the habit of tobacco smoking | |
| US4676259A (en) | Nicotine enhanced smoking device | |
| WO1987002870A1 (fr) | Application transdermique de nicotine | |
| JPS61254173A (ja) | 改良ニコチン分与装置および同製造法 | |
| US20030131857A1 (en) | Nicotine free cigarette substitute | |
| JPH0361419B2 (fr) | ||
| CN203676130U (zh) | 一种杆状烟料加热装置 | |
| KR100332840B1 (ko) | 쑥을 함유한 금연보조제 | |
| JP2001252063A (ja) | 紙巻きたばこ | |
| RU2157704C2 (ru) | Антиникотиновое антиалкогольное изделие | |
| JP2004229627A (ja) | 鼻で吸うタバコ代用物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |